Compare VNDA & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | NATH |
|---|---|---|
| Founded | 2002 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.4M | 413.9M |
| IPO Year | 2005 | 1996 |
| Metric | VNDA | NATH |
|---|---|---|
| Price | $5.39 | $96.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.90 | N/A |
| AVG Volume (30 Days) | ★ 858.1K | 21.3K |
| Earning Date | 05-06-2026 | 06-09-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 4.85 |
| Revenue | ★ $216,105,000.00 | $104,201,000.00 |
| Revenue This Year | $21.35 | N/A |
| Revenue Next Year | $37.40 | N/A |
| P/E Ratio | ★ N/A | $20.68 |
| Revenue Growth | ★ 8.72 | 7.81 |
| 52 Week Low | $4.14 | $88.67 |
| 52 Week High | $9.91 | $113.59 |
| Indicator | VNDA | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 32.43 | 23.85 |
| Support Level | $5.11 | $89.05 |
| Resistance Level | $5.58 | $101.80 |
| Average True Range (ATR) | 0.22 | 0.87 |
| MACD | -0.07 | -0.28 |
| Stochastic Oscillator | 8.61 | 31.17 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Nathan's Famous Inc is a branded licensor, wholesaler and retailer of products marketed under its brand. Its products are currently marketed for sale in thousands of locations, including supermarkets, mass merchandisers and club stores, selected foodservice locations and its company-owned and franchised restaurants throughout the United States and in twenty foreign countries. It considers itself to be in the foodservice industry. It has three segments Branded Product Program, Product Licensing, Restaurant Operations, of which majority of revenue is from Branded Product Program which derives from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors. It generates majority of revenue from United States.